MLKL and neoplasm: We included 191 HNSCC patients who received radical dissections between 2013 and 2018 (Table 2) and analyzed the expression of MLKL, p-MLKL in their tumor, and TAE tissues using immunohistochemistry (Fig. S1a, c).